Literature DB >> 7485819

Reduced activities of thiamine-dependent enzymes in brains of alcoholics in the absence of Wernicke's encephalopathy.

J Lavoie1, R F Butterworth.   

Abstract

The relative roles of alcohol per se, thiamine deficiency, and liver disease in the pathogenesis of alcohol-related brain damage have not been fully elucidated. In particular, the extent to which alterations of brain thiamine metabolism contribute to cognitive dysfunction in alcoholism in the absence of Wernicke's encephalopathy has not been established. In the present study, thiamine diphosphate-dependent enzymes were measured using standard spectrophotometric techniques in homogenates of brain tissue obtained at autopsy from eight alcoholic patients, all of whom died in hepatic coma without clinical or neuropathological evidence of Wernicke's encephalopathy and six nonalcoholic, age-matched controls, matched for autopsy delay time and free, at the time of death, from gross malnutrition or other neurological or psychiatric disorders. Transketolase activities were reduced in cerebellum (by 35%, p < 0.01), thalamus (by 35%, p < 0.01), frontal cortex (by 22%, p < 0.01), temporal cortex (by 20%, p < 0.01), and prefrontal cortex (by 19%, p < 0.01). Activities of the pyruvate dehydrogenase complex were selectively reduced in prefrontal cortex by 25% (p < 0.01). Activities of alpha-ketoglutarate dehydrogenase were within normal limits in all brain regions of alcoholic patients. The generalized reductions of transketolase activity undoubtedly result from thiamine deficiency. Previous studies suggest that the presence of liver disease may exacerbate thiamine deficiency in alcoholics. A sustained loss of transketolase activity in brain could result in disruption of pentose shunt activity and concomitant reductions in reducing equivalents and lipid metabolism within the cell. The selective loss of pyruvate dehydrogenase activity in prefrontal cortex of alcoholic cirrhotics could relate to the phenomenon of hepatic coma.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7485819     DOI: 10.1111/j.1530-0277.1995.tb00991.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  7 in total

Review 1.  Genetic factors influencing alcohol dependence.

Authors:  R D Mayfield; R A Harris; M A Schuckit
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

2.  Up-regulation of microRNAs in brain of human alcoholics.

Authors:  Joanne M Lewohl; Yury O Nunez; Peter R Dodd; Gayatri R Tiwari; R Adron Harris; R Dayne Mayfield
Journal:  Alcohol Clin Exp Res       Date:  2011-06-08       Impact factor: 3.455

3.  Thiamine Deficiency-Mediated Brain Mitochondrial Pathology in Alaskan Huskies with Mutation in SLC19A3.1.

Authors:  Karen Vernau; Eleonora Napoli; Sarah Wong; Catherine Ross-Inta; Jessie Cameron; Danika Bannasch; Andrew Bollen; Peter Dickinson; Cecilia Giulivi
Journal:  Brain Pathol       Date:  2014-10-29       Impact factor: 6.508

4.  Vermal atrophy of alcoholics correlate with serum thiamine levels but not with dentate iron concentrations as estimated by MRI.

Authors:  Matthias Maschke; Johannes Weber; Udo Bonnet; Albena Dimitrova; Julia Bohrenkämper; Sonja Sturm; Bernhard W Müller; Markus Gastpar; Hans-Christopher Diener; Michael Forsting; Dagmar Timmann
Journal:  J Neurol       Date:  2005-03-23       Impact factor: 4.849

Review 5.  Molecular targets of alcohol action: Translational research for pharmacotherapy development and screening.

Authors:  Giorgio Gorini; Richard L Bell; R Dayne Mayfield
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

Review 6.  Thiamine deficiency-related brain dysfunction in chronic liver failure.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2008-12-06       Impact factor: 3.584

7.  Protection of Cholinergic Neurons against Zinc Toxicity by Glial Cells in Thiamine-Deficient Media.

Authors:  Sylwia Gul-Hinc; Anna Michno; Marlena Zyśk; Andrzej Szutowicz; Agnieszka Jankowska-Kulawy; Anna Ronowska
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.